Health

Singapore Halts Registration for Covid-19 Antibody Assay After Stopping Trial of US Drug Manufacturer, Health News & Top Stories

[ad_1] SINGAPORE – The National Center for Infectious Diseases (NCID) temporarily stopped enrolling Covid-19 patients for a monoclonal antibody trial after the US pharmaceutical company that developed the drug had to stop the trial last week due to concerns from security. Singapore is only the third country to participate in …

Read More »